Evidence map›Paper›PMID 31303792›Full record

ArticleCancer management and research2019

Evaluation of therapeutic efficacy with CytoSorter

Weihui Zheng, Yibiao Zhang, Liang Guo, Shengye Wang, Meiyu Fang, Weimin Mao, Jianlin Lou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Circulating biomarkers in oral cancer: Unravelling the mystery.Journal of oral and maxillofacial pathology : JOMFP
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Weihui ZhengCenter of Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215000, People's Republic of China.
Yibiao ZhangDepartment of Clinical Laboratory, Jinhua Guangfu Hospital, Jinhua 321000, People's Republic of China.
Liang GuoDepartment of Head and Neck Surgery, Zhejiang Cancer Hospital & Creative Laboratory of Head and Neck Oncology in Zhejiang Province, Hangzhou 310022, People's Republic of China.
Shengye WangDepartment of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, People's Republic of China.
Meiyu FangDepartment of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, People's Republic of China.
Weimin MaoCenter of Oncology, the First Affiliated Hospital of Soochow University, Suzhou 215000, People's Republic of China.
Jianlin LouDepartment of Head and Neck Surgery, Zhejiang Cancer Hospital & Creative Laboratory of Head and Neck Oncology in Zhejiang Province, Hangzhou 310022, People's Republic of China.
Zhejiang Cancer Hospital · CNFirst Affiliated Hospital of Soochow University · CNGuang Fu Hospital · CNHangzhou Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulating tumor cellshead and neck carcinomainduction chemotherapysquamous cell carcinoma

Identifiers

PMID31303792
PMCPMC6603285
OpenAlexW2954886659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.